GDTC CytoMed Therapeutics Limited Forecast, Technical & Fundamental Analysis

Industry Biotechnology

Get AI intraday signals

View a ticker or compare two or three

Compare

Ad is loading...

A.I. Advisor

published Earnings

GDTC is expected to report earnings to rise 33.33% to -3 cents per share on November 27

CytoMed Therapeutics Limited GDTC Stock Earnings Reports

Q3'24

Est.

$-0.04

Q2'24

Beat

by $0.01

Q1'24

Est.

$-0.04

Q4'23

Est.

$-0.05

Q3'23

Beat

by $0.01

The last earnings report on September 30 showed earnings per share of -2 cents, beating the estimate of -3 cents. With 6.15K shares outstanding, the current market capitalization sits at 26.17M.

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

1 Commonwealth Lane

Phone

+65 62507738

Employees

Web

https://w2.cytomed.sg

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
CSWC	23.10	0.20	+0.87%
Capital Southwest Corp
VLY	10.18	0.04	+0.39%
Valley National Bancorp
KEYS	157.30	-3.91	-2.43%
Keysight Technologies
ACRV	7.93	-0.46	-5.48%
Acrivon Therapeutics
BTAI	0.62	-0.05	-6.92%
BioXcel Therapeutics

GDTC and Stocks

Correlation & Price change

A.I.dvisor tells us that GDTC and CVKD have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GDTC and CVKD's prices will move in lockstep.

Ticker / NAME	Correlation To GDTC	1D Price Change %
GDTC	100%	-5.13%
CVKD - GDTC	29% Poorly correlated	-0.89%
ADIL - GDTC	27% Poorly correlated	+0.99%
TENX - GDTC	25% Poorly correlated	-1.15%
RXRX - GDTC	23% Poorly correlated	-3.32%
NURPF - GDTC	21% Poorly correlated	N/A
More